Quibim - About the company
Quibim is a series A company based in Valencia (Spain), founded in 2015 by Angel Alberich-Bayarri and Luis Marti-Bonmati. It operates as a Developer of medical imaging software for radiomics and biomarker analysis. Quibim has raised $60M in funding from investors like Amadeus Capital, Angels Capital and Asabys Partners. The company has 1107 active competitors, including 296 funded and 146 that have exited. Its top competitors include companies like Guardant Health, Natera and Qure.ai.
Company Details
Developer of medical imaging software for radiomics and biomarker analysis. This software extracts quantitative features from medical images to support clinical research and diagnostic workflows. The platform manages, indexes, and harmonizes imaging data while integrating with electronic health records. It provides automated tools for analyzing specific organ systems, including the prostate, brain, liver, breast, and lung. These tools facilitate the calculation of volumetric data and the identification of imaging patterns to assist in disease classification and monitoring. The technology functions as a cloud-based system for processing and storing medical imaging data in compliance with data security standards.
- Website
- quibim.com
- Email ID
- *****@quibim.com
- Phone Number
- +34 **********
Key Metrics
Founded Year
2015
Location
Valencia, Spain
Stage
Series A
Total Funding
$60M in 15 rounds
Latest Funding Round
Investors
Ranked
27th among 1107 active competitors
Employee Count
116 as on Sep 30, 2026
Legal entities associated with Quibim
Quibim is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
QUIBIM, S.L CIN: 1626656 , Spain, Active | Apr 23, 2021 | - | - | - |
QUIBIM INC. CIN: 7592503 , United States, Active | Sep 05, 2019 | - | 3 (As on Dec 01, 2023) | - |
QUIBIM LIMITED CIN: 14023736 , United Kingdom, Active | Apr 03, 2022 | - | 2 (As on Dec 31, 2024) |
Sign up to download Quibim's company profile
Quibim's funding and investors
Quibim has raised a total funding of $60M over 15 rounds. Its first funding round was on Jul 27, 2016. Its latest funding round was a Series A round on Jan 28, 2025 for $*****. 11 investors participated in its latest round. Quibim has 20 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Quibim:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 28, 2025 | 3626480 | Series A | 5233242 | 3828257 | 2841073 | 9126965 |
Oct 01, 2020 | 9732101 | Grant (prize money) | 2213609 | 5471852 | 9835538 | |
Sep 01, 2020 | 2208631 | Grant (prize money) | 7712324 | 3025309 | 3583993 |
View details of Quibim's funding rounds and investors
Quibim's founders and board of directors
Founder? Claim ProfileThe founders of Quibim are Angel Alberich-Bayarri and Luis Marti-Bonmati. Angel Alberich-Bayarri is the CEO of Quibim.
Here are the details of Quibim's key team members:
- Angel Alberich-Bayarri: Co-Founder & CEO of Quibim and founder of 1 other company. Contact Info: 1 email address
- Luis Marti-Bonmati: Co-Founder of Quibim. Contact Info: 1 email address
View details of Quibim's Founder profiles and Board Members
Quibim's employee count trend
Quibim has 116 employees as of Sep 26. Here is Quibim's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Quibim's Competitors and alternates
Top competitors of Quibim include Guardant Health, Natera and Qure.ai. Here is the list of Top 10 competitors of Quibim, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Guardant Health 2012, Redwood City (United States), Public | Developer of digital sequencing technology for cancer detection | $557M | 80/100 | |
2nd | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 79/100 | |
3rd | Developer of artificial intelligence software for medical imaging diagnostic analysis | $123M | 74/100 | ||
4th | AIdoc 2016, New York City (United States), Series E | Developer of clinical AI solutions for healthcare imaging and patient management | $534M | 71/100 | |
5th | BillionToOne 2015, San Francisco (United States), Public | Provider of cell-free cancer liquid biopsy test | $389M | 71/100 | |
6th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 67/100 | |
7th | Subtle Medical 2017, Palo Alto (United States), Series C | AI-driven solutions for medical diagnostic imaging | $86M | 67/100 | |
8th | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | 66/100 | |
9th | Developer of artificial intelligence software for medical imaging diagnostic analysis | $40M | 66/100 | ||
10th | Cleerly 2016, Denver (United States), Series C | Provider of an AI-driven platform for coronary artery disease assessment | $578M | 66/100 | |
27th | Developer of medical imaging software for radiomics and biomarker analysis | $60M | 61/100 |
Looking for more details on Quibim's competitors? Click here to see the top ones
Quibim's Investments and acquisitions
Quibim has made no investments or acquisitions yet.
Reports related to Quibim
Here is the latest report on Quibim's sector:
News related to Quibim
Media has covered Quibim for a total of 7 events in the last 1 year, 2 of them have been about company updates and 2 about people movement.
•
•
Quibim, the Only Healthtech Selected by New York for Its Strategic AI ProgramQuibim•May 11, 2026•Quibim
•
Quibim partners with Germany’s Vara to bring Europe’s leading breast-cancer screening AI to SpainQuibim•Apr 14, 2026•Quibim, Vara
•
•
Quibim Appoints Jeanne Bolger As Independent Director & Advisor To Accelerate Growth In Life SciencesQuibim•Jan 27, 2026•Quibim
•
Generalitat Valenciana rewards Quibim for its commitment to excellence and social responsibilityQuibim•Jan 08, 2026•Quibim
•
•
Quibim’s AI Tool for Prostate Cancer Detection Selected for NHS Rollout Across Seven UK HospitalsQuibim•Jul 09, 2025•Quibim
•
•
Are you a Founder ?
FAQs about Quibim
Explore our recently published companies
- Seededge Solutions - Pune based, Unfunded company
- Secuarden AI - Melbourne based, 2026 founded, Unfunded company
- Secretair AI - France based, 2025 founded, Unfunded company
- Second Loop AI - Unfunded company
- Seawin AI - Unfunded company
- Seamless IT AI - United States based, Unfunded company
